Primary experimental study on the reference method for the counting of red blood cells and white blood cells

doi:10.3969/j.issn.1673-8640.2015.06.023

Abstract

Abstract: Objective

To investigate the reference method for red blood cell (RBC) and white blood cell (WBC) counts, and to establish standardized determination platform which will provide technical support for blood cell counting trueness verification test.

Methods

The reference method was established according to relevant documents of the International Council for Standardization in Hematology (ICSH) and the standard of the People's Republic of China (WS/T 245-2005). The S-CAL cell calibrator, 5C cell control, aperture instrument concentration control, processed whole blood and fresh whole blood samples were determined on Z2 particle counter. Parameters such as within-run and between-run coefficients of variance (CV), coincidence counting correction, stability and comparability were evaluated.

Results

The method showed that within-run CV was<1%, and between-run CV met the requirements of the Clinical and Laboratory Standards Institute (CLSI) H26-A2. The results demonstrated the biases of coincidence counting correction in RBC and WBC counts were <1%. RBC and WBC of processed fresh whole blood samples were stable after storage for above 5 d. The biases of fresh whole blood RBC and WBC between Z2 particle counter and BECKMAN-COULTER ACT diff Ⅱ, BECKMAN-COULTER LH-750, SYSMEX K-4500, SYSMEX XE-2100 hematology analyzers were ≤±2% and ≤±4%.

Conclusions

The reference method for RBC and WBC counting by Z2 particle counter has been established basically. Precision, coincidence counting correction, accuracy, stability and comparability are conformed to the requirements. It provides the technical support for blood cell counting trueness verification test.

Key words: Red blood cell, White blood cell, Counting, Reference method, Z2 particle counter

CLC Number:

R446.11

XU Lei, WANG Qing, MIAO Yingbo, SONG Ying, WANG Guofei, ZHU Peichao, GUO Xiaojun. Primary experimental study on the reference method for the counting of red blood cells and white blood cells[J]. Laboratory Medicine, 2015, 30(6): 641-645.

Figures/Tables 7

项目	稀释管1	稀释管2	稀释管3	稀释管4
次级稀释(mL)	0.02+20^*	0.04+20^*	0.06+20^*	0.08+20^*
X轴设定值(%)	25.07	50.10	75.07	100.00
细胞计数(次数)	12	6	4	3

项目	测定次数	$x ?$	s	CV (%)	参考方法要求
RBC(×10¹²/L)	10	4.200	0.018	0.43	<1%
WBC(×10⁹/L)	10	8.550	0.065	0.76	<1%
浓度质控品	10	1.004	0.008	0.80	<1%

项目	测定次数	$x ?$	s	CV (%)	参考方法要求
RBC(×10¹²/L)	10	4.200	0.018	0.43	<1%
WBC(×10⁹/L)	10	8.550	0.065	0.76	<1%
浓度质控品	10	1.004	0.008	0.80	<1%

项目批号	测定天数(d)	$x ?$	极差	CLSI H26-A2 极差要求^[3]
RBC(×10¹²/L)889700	8	5.451	0.14	≤±0.15
RBC(×10¹²/L)879300	15	4.191	0.10	≤±0.15
WBC(×10⁹/L)889700	8	9.823	0.30	≤±0.3
WBC(×10⁹/L)868100	15	3.748	0.30	≤±0.3

项目批号	测定天数(d)	$x ?$	极差	CLSI H26-A2 极差要求^[3]
RBC(×10¹²/L)889700	8	5.451	0.14	≤±0.15
RBC(×10¹²/L)879300	15	4.191	0.10	≤±0.15
WBC(×10⁹/L)889700	8	9.823	0.30	≤±0.3
WBC(×10⁹/L)868100	15	3.748	0.30	≤±0.3

项目	重合计数校正值	靶值	偏倚(%)	方程式
RBC(×10¹²/L)	4.139 5	4.11	0.72	Y=-0.000 26X+4.139 5
WBC(×10⁹/L)	9.032 4	9.00	0.36	Y=0.000 71X+9.032 4

项目	处理方式	样品号	每周开瓶次数	稳定天数	目标值^*	结果分布	偏倚分布 (%)	允许偏倚 (%)
RBC(×10¹²/L)	方式1	0	2	22	5.193 6	5.093 85.248 7	-1.92~1.06	≤±2%
	方式2	3	2	13	3.740 4	3.671 93.757 6	-1.83~0.46	≤±2%
		23	2	9	4.954 0	4.868 14.868 2	-1.74~-1.74	≤±2%
		4	1	30	4.433 9	4.359 64.488 5	-1.68~1.23	≤±2%
	方式3	26	2	15	4.425 3	4.340 34.380 5	-1.921.01	≤±2%
项目	处理方式	样品号	每周开瓶次数	稳定天数	目标值^*	结果分布	偏倚分布 (%)	允许偏倚 (%)
WBC(×10⁹/L)	方式1	0	2	5	5.431	5.4955.552	-1.19~2.24	≤±4%
	方式2	3	2	8	5.690	5.4835.898	-3.65~3.65	≤±4%
		23	2	13	9.174	8.9039.458	-2.95~3.10	≤±4%
		4	1	28	5.761	5.7565.841	-0.09~1.39	≤±4%
	方式3	26	2	6	5.922	5.881	-0.69	≤±4%

仪器	RBC(×10¹²/L)				WBC(×10⁹/L)
仪器	样本数	与Z2的绝对误差	偏倚 (%)	允许偏倚 (%)	样本数	与Z2的绝对误差	偏倚 (%)	允许偏倚 (%)
Z2颗粒计数仪	1324				1320
ACT diffⅡ	16	-0.042	-0.94	≤±2%	17	-0.08	-1.36	≤±4%
LH-750	21	-0.012	-0.27	≤±2%	20	-0.11	-1.83	≤±4%
K-4500	24	0.032	0.73	≤±2%	13	-0.11	-1.93	≤±4%
XE-2100	13	0.042	0.95	≤±2%	13	0.06	1.05	≤±4%

[1]	International Council for Standardization in Hematology.Reference method for the enumeration of erythrocytes and leukocytes[J]. Clin Lab Haemat,1994,16(2):131-138.
[2]	WS/T245-2005 红细胞和白细胞计数参考方法[S].2006.
[3]	Clinical and Laboratory Standards Institute. Validation, verification,and quality assurance of automated hematology analyzers; approved standard-second edition[S].H26-A2, CLSI,2010.
[4]	彭明婷,谷小林,陆红,等.红细胞和白细胞计数参考方法的结果比对[J].中华检验医学杂志,2004,27(9):567-569.
[5]	宋颖,胡晓波,居漪,等.红细胞计数参考方法的不确定度研究[J].检验医学,2005,20(3):185-188.
[6]	许蕾,宋颖,李泳,等.血小板计数参考方法测量不确定度的实验研究[J].检验医学,2009,24(3):211-214.
[7]	彭黎明,王伟鑫,白丽霞.Z2细胞计数仪计数白细胞和红细胞的性能评价[J].检验医学,2007,22(3):257-262.

[1]	LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864.
[2]	GUO Jie, LI Haixia, LI Xiaoyun. Correlation of preoperative RPR in peripheral blood with the prognosis of endometrial carcinoma patients [J]. Laboratory Medicine, 2023, 38(7): 675-679.
[3]	DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090.
[4]	DUAN Yong, WANG Yong, ZHANG Yumin, ZENG Haitao, LIU Qing. Predictive value of red blood cell distribution width for in-hospital mortality in ICU patients with heart failure：a retrospective study based on the MIMIC-Ⅲ database [J]. Laboratory Medicine, 2023, 38(10): 951-956.
[5]	WANG Chong, ZHU Jie, YANG Shuo, GU Meixiu, PAN Baishen, WANG Beili, GUO Wei. Feasibility study of automated hematology analyzer on routine cell counts of serous cavity effusion [J]. Laboratory Medicine, 2022, 37(6): 551-556.
[6]	TANG Ningbo, LIU Guancai, LIU Xiaoyu, YANG Fengfan, GONG Zhimei, SUN Keqi. Establishment and evaluation for the determination of serum digitoxin as a candidate reference method [J]. Laboratory Medicine, 2022, 37(5): 456-462.
[7]	MA Jianguo, ZHU Xiaolin, DING Yongguang, YIN Meng, LI Hongchun. Predictive values of red blood cell distribution width and myocardial markers for acute myocardial infarction in patients with CAS [J]. Laboratory Medicine, 2022, 37(12): 1164-1168.
[8]	SONG Ying, HAN Jiaojiao, ZHAO Qiang, XU Chong. Establishment and performance evaluation of peripheral blood leukocyte classification reference method by flow cytometry [J]. Laboratory Medicine, 2022, 37(12): 1190-1195.
[9]	LIU Chunxiao, YI Changlin, WANG Xiaoshan, ZHU Yongzhen, LUO Aner, CHEN Changqiang. Roles of MxA，CRP and WBC count in the differential diagnosis of acute respiratory tract viral and bacterial infections [J]. Laboratory Medicine, 2022, 37(10): 944-947.
[10]	LI Qing, JU Yi, TANG Liping, JIN Zhonggan, SUN Hewei. Application of candidate reference method of apolipoprotein A1 and apolipoprotein B in external quality assessment [J]. Laboratory Medicine, 2021, 36(3): 259-262.
[11]	SUN Hewei, JU Yi, ZHU Lingfeng, LI Qing, JIN Zhonggan, ZHANG Sujie. Isotope dilution liquid chromatography tandem mass spectrometry candidate reference method for serum testosterone [J]. Laboratory Medicine, 2021, 36(10): 1064-1069.
[12]	ZOU Jihua, LI Quanle, SHEN Min, ZHANG Man, YANG Xiaodong, TU Minmin, FENG Dongfang, SUN Hongna. Establishment and performance evaluation of candidate reference measurement procedure for serum aldosterone by liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2020, 35(8): 811-817.
[13]	ZHOU Xin, ZHANG Jue, CHEN Liying. Study on the main causes for false increasing of white blood cells and small round epithelial cells determined by UF-1000i urine sediment analyzer [J]. Laboratory Medicine, 2020, 35(5): 444-446.
[14]	ZHOU Xin, ZHANG Jue, CHEN Liying. Study on the main causes for false increasing of white blood cells and small round epithelial cells determined by UF-1000i urine sediment analyzer [J]. Laboratory Medicine, 2020, 35(5): 444-446.
[15]	GUO Ping, ZHUANG Lihua, CHEN Liting, WANG Jianbiao, WU Jianfeng. Roles of MCV,RDW and SAA in the progression of chronic hepatitis B [J]. Laboratory Medicine, 2020, 35(11): 1153-1157.